Osia® Implant
Designed to discreetly work with your body to help you hear and communicate with ease. Learn about the innovative technology behind the Osia® OSI300 Implant.
What you'll find on this page
- The Osia® OSI300 Implant
- Understanding Piezo Power™ technology
- MRI considerations with the Osia Implant
A hearing implant reimagined
The Osia OSI300 is placed under the skin and works by bypassing damaged areas of the outer and middle ear, which sends sound directly to the inner ear. The implant is attached to the BI300 which is Cochlear’s latest titanium implant featuring TiOblast™ surface technology. The implant is designed to promote faster and stronger integration to the bone (through a natural process known as osseointegration).
Piezo Power™ technology
The Osia System's Piezo Power™ transducer, in the OSI300 Implant, creates vibrations that are sent through the bone directly to your inner ear. One of the advantages of the Piezo Power transducer is its ability to vibrate at high frequencies1. This means that in the most difficult listening situations, like a noisy restaurant or a busy classroom, you will hear those sounds that bring clarity to speech understanding.
Lifetime testing shows that Piezo Power technology provides powerful and consistent performance over time.2
The power to hear more
The powerful transducer can help those with hearing loss up to 55 dB SNHL.* This means it can help address a range of hearing loss levels and can help you hear now as well as if your hearing loss gets worse over time.
"I’ve followed Cochlear for quite a few years, and I knew they had a great reputation. So, I was pretty confident. I’m a bit adventurous, so I thought, why not?"
- Adrian, Osia System recipient
Designed to implant, made to last
The Piezo Power transducer has a completely different design than traditional bone conduction transducers. The Osia System has demonstrated 99.92% reliability since it's release3, and accelerated lifetime testing has demonstrated consistent performance for the Piezo Power transducer over time.4
Significant improvement in hearing
We’ve tested the first generation Osia System in trials across multiple clinics around the world. After one year, people who received the new technology showed significant hearing improvements, even in noisy environments.5
Osia System users show a significant improvement in their ability to understand speech in quiet and in noisy environments.5
Designed for safe MRIs
Many people need an MRI scan at some point in their life. With the OSI300 Implant, you're able to undergo high-resolution MRI scans at 1.5 and 3.0 Tesla strength without having to worry about your implant.** Testing shows that the performance of the Piezo Power transducer remains consistent after MRI exposure.6
More information
Disclaimer
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
For a full list of Cochlear’s trademarks, please visit our Terms of Use page.
In the United States, the Osia 2 System is cleared for children ages twelve and older. In Canada, the Osia 2 System is approved for children ages five and older.
*SNHL means sensorineural hearing level
**Prior to receiving an MRI, please consult with your clinician about proper precautions.
Reference
- Osia System R5 Datasheet. cochlear Limited, Australia. 2023; D1991788.
- Dotevall M. Osia OSI200 Implant Technical Brief. Cochlear Bone Anchored Solutions AB, Sweden. 2020; D1602089.
- Cochlear Limited Osia reliability Report. Cochlear Limited, Sweden. 2023; D1841762.
- Cochlear Limited. OSI200 Implant Accelerated Life Test Report. Cochlear Limited, Australia. 2019; D1439967.
- Mylanus EAM, Hua H, Wigren S, et al. Multicenter Clinical Investigation of a New Active Osseointegrated Steady-State Implant System. Otol Neurotol. 2020;41(9):1249-1257.
- Cochlear Limited. OSI200 implant MRI Safety Verification Report. Cochlear Limited, Australia. 2019; D1439962.